Elevated tumor necrosis factor in serum is associated with increased retinal ischemia in proliferative eales' disease

Pathobiology

Volumn 78, Issue 5, 2011, Pages 261-265

  Saxena, Sandeep ^a   Khanna, Vinay K ^b   Pant, Aditya B ^b   Meyer, Carsten H ^c   Singh, Vijay K ^d  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^c UNIVERSITY OF BONN   (Germany)

^d ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

Cell death signaling; Cytokine; Eales' disease; Neovascularization; Retina; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EALES DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); OPHTHALMOSCOPY; OPTIC DISK; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA CAPILLARY; RETINA ISCHEMIA;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; ISCHEMIA; MALE; NEOVASCULARIZATION, PATHOLOGIC; RETINA; RETINAL VASCULITIS; RETINAL VESSELS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051661581     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000329589     Document Type: Article

References (28)

1. Gieser SC, Murphy RP: Eales disease; in Ryan SJ (ed): Retina Vol II. Medical Retina. St Louis, CV Mosby, 1994, pp 1503-1507.
2. Atmaca LS, Idil A, Gunduz K: Visualization of retinal vasculitis in Eales disease. Ocul Immunol Inflamm 1993; 1: 41-44.
3. Bali T, Saxena S, Kumar D, Nath R: Response time and efficacy of oral methotrexate pulsed therapy in idiopathic retinal periphlebitis. Eur J Ophthalmol 2005; 15: 374-378. (Pubitemid 40943936)
4. Kumar D, Saxena RC, Saxena S: Vitreous haemorrhage in Eales disease. Afro-Asian J Ophthalmol 1995; 13: 109-112.
5. Saxena S, Rajasingh J, Biswas S, Kumar D, Shinohara T, Singh VK: Cellular response to retinal S-antigen and interphotoreceptor retinoid binding protein fragments in patients with Eales disease. Pathobiology 1999; 67: 37-44.
6. Saxena S, Srivastava P, Kumar D, Khanna VK, Seth PK: Decreased platelet membrane fluidity in retinal periphlebitis in Eales disease. Ocul Immunol Inflamm 2006; 14: 113-116.
7. Saxena S, Kumar D: A new staging system for idiopathic retinal periphlebitis. Eur J Ophthalmol 2004; 14: 236-239. (Pubitemid 38901795)
8. Inomata H, Ishibashi T, Murata T, Iwasaki M, Tahara A, Hata K, et al: Intraocular neovascularization. Nippon Ganka Gakkai Zasshi 1997; 101: 90-96.
9. Kawashima M, Shoji J, Kamura Y, Sato Y: Role of chemokines in the vitreous of proliferative diabetic retinopathy. Nippon Ganka Gakkai Zasshi 2005; 109: 596-602.
10. Armstrong D, Ueda T, Ueda T, et al: Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis 1998; 2: 93-104. (Pubitemid 128511976)
11. Dinarello CA: Proinflammatory cytokines. Chest 2000; 118: 503-508. (Pubitemid 30637822)
12. Kriegler M, Perez C, DeFay K, Albert I, Lu SD: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 1988; 53: 45-53.
13. Tang P, Hung MC, Klostergaard J: Human pro-tumor necrosis factor is a homotrimer. Biochemistry 1996; 35: 8216-8225. (Pubitemid 26234923)
14. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, et al: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997; 385: 729-733. (Pubitemid 27098094)
15. Locksley RM, Killeen N, Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487-501. (Pubitemid 32201945)
16. Wajant H, Pfizenmaier K, Scheurich P: Tumor necrosis factor signaling. Cell Death Differ 2003; 10: 45-65. (Pubitemid 36511832)
17. Chen G, Goeddel DV: TNF-R1 signaling: a beautiful pathway. Science 2002; 296: 1634-1635. (Pubitemid 34579145)
18. Gaur U, Aggarwal BB: Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003; 66: 1403-1408. (Pubitemid 38373326)
19. Hunter CA, Timans J, Pisacane P, Menon S, Cai G, Walker W, et al: Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma inducing factor on the production of interferon-gamma by natural killer. Eur J Immunol 1997; 27: 2787-2792. (Pubitemid 27478344)
20. Saxena S, Pant AB, Khanna VK, Singh K, Kumar D, Singh VK: Interleukin-1 and tumor necrosis factor-alpha: novel targets for immunotherapy in Eales disease. Ocul Immunol Inflamm 2009; 17: 201-206.
21. Saxena S, Pant AB, Khanna VK, Singh K, Shukla RK, Meyer CH, Singh VK: Tumor necrosis factor-mediated severity of idiopathic retinal periphlebitis in young adults (Eales disease): implication for anti-TNF-therapy. J Ocul Dis Biol Inform 2010; 3: 35-38.
22. Sen A, Paine SK, Chowdhury IH, Mondal LK, Mukherjee A, Biswas A, et al: Association of interferon-gamma, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms with occurrence and severity of Eales disease. Invest Ophthalmol Vis Sci 2011; 52: 171-178.
23. Saxena S, Kumar D, Maitreya A, Srivastava P, Khanna VK, Nath R, et al: Retinal neovascularization in Eales disease. Ann Ophthalmol 2003; 35: 25-27. (Pubitemid 36713471)
24. Saxena S, Kumar D: Topographic distribution of retinal neovascularization in Eales disease. Ann Ophthalmol 2005; 37: 273-275. (Pubitemid 43170227)
25. Kramer M, Dadon S, Hasanreisoglu M, Monselise Y, Avraham BR, Feldman A, Eldar I, Weinberger D, Goldenberg-Cohen N: Proinflammatory cytokines in a mouse model of central retinal artery occlusion. Mol Vis 2009; 15: 885-894.
26. Berger S, Savitz SI, Nijhawan S, Singh M, David D, Rosenbaum PS, Rosenbaum DM: Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2008; 49: 3605-3610.
27. Yoshida S, Yoshida A, Ishibashi T: Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefes Arch Clin Exp Ophthalmol 2004; 242: 409-413. (Pubitemid 38801529)
28. Abhimanyu, Mangangcha IR, Jha P, Arora K, Mukerji M, Banavaliker JN, Indian Genome Variation Consortium, et al: Differential serum cytokine levels are associated with cytokine gene polymorphisms in north Indians with active pulmonary tuberculosis. Infect Genet Evol 2011; 11: 1015-1022.